Viemed Healthcare, Inc. (NASDAQ:VMD ) Q4 2024 Earnings Conference Call March 11, 2025 11:00 AM ET Company Participants Todd Zehnder - COO Trae Fitzgerald - CFO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Andrew Rem - Odinson Partners Operator Greetings, and welcome to the Viemed Healthcare Year-End 2024 Earnings Call. At this time all participants are in a listen-only mode.
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025.
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2024 Results Conference Call November 7, 2024 12:00 PM ET Company Participants Todd Zehnder - Chief Operating Officer Casey Hoyt - Chief Executive Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Ilya Zubkov - Freedom Broker Operator Greetings, and welcome to Viemed's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024.
Upgraded Viemed Healthcare to 'Buy' due to bullish technicals, strong Q2 earnings, and promising growth trends in ventilator and sleep businesses. Bullish MACD crossover and strong buying volume signal potential for sustained share price increase. Q2 revenue hit $55 million, with notable organic growth and successful sales force restructuring driving performance.
LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2024.
LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET.
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2023 Earnings Conference Call November 2, 2023 11:00 AM ET Company Participants Todd Zehnder - COO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Limited Michael Freeman - Raymond James Operator Greetings, and welcome to Viemed's 3Q 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
LAFAYETTE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the following upcoming investor conferences:
Viemed Healthcare's equity stock has consolidated by ~20% after a strong rally, but the company's economic outlook remains unchanged. The acquisition of HMP has added potential value to VMD, expanding its geographical reach and bringing revenue synergies. Viemed Healthcare's Q2 earnings showed strong growth, with sales up 31% YoY, and the company expects continued expansion in FY'23 and FY'24.